Julie C. Friedman

Julie C. Friedman

Auto-generated profile, based on publicly available information

Julie C. Friedman

University of Colorado Department of Obstetrics and Gynecology, Section of Pediatric and Adolescent Gynecology, Aurora, Colorado

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2022 in F&S Reports
Verified
Journal Article
Open access
JFJulie Friedman
Julie Friedman
JSJeanelle Sheeder
Jeanelle Sheeder
ALAaron Lazorwitz
Aaron Lazorwitz
APAlex Joel Polotsky
Alex Joel Polotsky
To address the knowledge gap surrounding herbal medicine and supplement usage patterns and supplement-prescription medication interactions among patients seeking treatment for infertility. Cross-sectional survey study. Academic infertility practice. Ninety-five reproductive-aged patients. Not applicable. Use of herbal medications and supplements, baseline demographics, history of infertility treatments, and potential supplement-medication interactions. We surveyed 95 participants with a median age of 35 years. Overall, 68.4% of patients reported ever having used supplements or herbal medicines in the past. Current use of herbal supplements and vitamins was reported by 53.7% and 93.7% of participants, respectively, with a median of 2 (range 19) supplements used per person. There were no significant associations between patient demographics, comorbidities, or infertility treatments with increased rates of supplement use. The most commonly used herbal supplements were: green tea (n = 14), chamomile (n = 12), peppermint (n = 9), turmeric (n = 8), elderberry (n = 7), ginger (n = 7), maca (6) with the most common modalities being pills/capsules (23.8%) and tea (42.3%). The most common reasons for use were: general health and wellness (24.5%), immune support (16.2%), stress (14.0%), and fertility (15.0%). Patients used maca (n = 5), chasteberry (n = 3), goji berry (n = 2), ginger (n = 2), yam-based progesterone (n = 2), and combination product (n = 2) for fertility purposes. A total of 7.9% of patients learned about these products from their general health care provider, and 33.3% of supplements were disclosed by patients to their provider. We identified 41 moderate-risk supplement-drug interactions, with 12 of these interactions attributed to infertility therapies. Based on the interaction checker, the most commonly proposed mechanisms of interaction were CYP3A4 and CYP2C19 inhibition. In terms of safety in pregnancy, cannabidiol and chasteberry were suggested to be "possibly unsafe in pregnancy," and red raspberry leaf "likely unsafe in pregnancy" without direct medical supervision. We found over two thirds of women seeking treatment for infertility reported past and over half reported current herbal medicine and supplement use. Notably, the Natural Medicines Interaction Checker suggested high rates of moderate-risk supplement-drug interactions and possible harmful effects in early pregnancy. Our results call for further investigation of clinically relevant supplement interactions with infertility therapies.

1 June 2022 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
JFJulie C. Friedman
Julie C. Friedman
EBEliza Buyers
Eliza Buyers
JLJaime Laurin
Jaime Laurin
KHKaren Hampanda
Karen Hampanda
VAVeronica I. Alaniz
Veronica I. Alaniz

14 August 2024 in Current Opinion in Obstetrics and Gynecology
Verified
Journal Article
Closed access
JFJulie C. Friedman
Julie C. Friedman
BCBianca Cannon
Bianca Cannon
NTNichole Tyson
Nichole Tyson
MKMelissa Kang
Melissa Kang
Purpose of review: There are high rates of sexually transmitted infections (STIs) worldwide. Adolescents and young adults (AYA) ages 15–24 years remain one of the populations that is most vulnerable to STIs. The goal of this review is to summarize recent international updates in adolescent STI screening and treatment. Recent findings: Normalizing sexual history taking and STI testing, and advocating for adolescents to receive comprehensive sexuality education improves stigma surrounding sexual health. The global rise in syphilis is pervasive and includes high rates of infection among AYA and women of reproductive age – universal screening may be indicated depending on local epidemiology. Gonococcal antimicrobial resistance remains a significant public health concern worldwide, thus judicious use of antimicrobials and reporting cases of resistance is crucial. Sexual health services are increasingly using virtual platforms, which may be an effective strategy for STI testing and treatment among AYA. Summary: Specific areas of focus to address the STI epidemic among AYA include reducing stigma surrounding sexual health, screening, and treatment of STIs, especially with the global rise in syphilis and high rates of gonorrhea resistance, in addition to increased use of telehealth services as effective education and intervention strategies.

7 November 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
LELauren L. Evans
Lauren L. Evans
SVSage A. Vincent
Sage A. Vincent
SBSamantha Bothwell
Samantha Bothwell
JFJulie C. Friedman
Julie C. Friedman
VAVeronica Alaniz
Veronica Alaniz
ABAndrea Bischoff
Andrea Bischoff

6 December 2023 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
JFJulie C. Friedman
Julie C. Friedman
JSJeanelle Sheeder
Jeanelle Sheeder
APAlex Joel Polotsky
Alex Joel Polotsky
ALAaron Lazorwitz
Aaron Lazorwitz

3 August 2024 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
JFJulie C. Friedman
Julie C. Friedman
KHKendra Hutchens
Kendra Hutchens
KHKaren Hampanda
Karen Hampanda
SSStephen Scott
Stephen Scott
PHPatricia Huguelet
Patricia Huguelet
VAVeronica I. Alaniz
Veronica I. Alaniz